VTGN — VISTAGEN THERAPEUTICS INC

Ownership history in Persistent Asset Partners Ltd  ·  5 quarters on record

This page tracks every 13F SEC filing in which Persistent Asset Partners Ltd reported a position in VISTAGEN THERAPEUTICS INC (VTGN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.29% (2024 Q4)
Avg. % of fund
0.17%
First filed
2024 Q4
Last filed
2025 Q4
Quarters held
5
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 26,612 -48,707 -64.7% 0.01% $18K $0.66
2025 Q3 REDUCED 75,319 -11,500 -13.2% 0.18% $267K $3.55
2025 Q2 REDUCED 86,819 -34,832 -28.6% 0.13% $174K $2.00
2025 Q1 UNCHANGED 121,651 — 0% 0.26% $304K $2.50
1 older quarter hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    VTGN price (monthly, adj. close)

Other funds also holding VTGN

As of 2025 Q4 — sorted by position size

LUMINUS MANAGEMENT LLC 3Y 7Y 0.2% TCG Crossover Management, LLC 3Y 0.06% ORBIMED ADVISORS LLC 3Y 7Y 0.04% Seven Fleet Capital Management LP 0.03% ADAR1 Capital Management, LLC 0.03% AdvisorShares Investments LLC 3Y 0.03% Ikarian Capital, LLC 3Y 0.03% STEMPOINT CAPITAL LP 0.02% ADAR1 Capital Management, LLC 0.01% OCCUDO QUANTITATIVE STRATEGIES LP 3Y 0.0%
← Back to Persistent Asset Partners Ltd Holdings